|
Authors | Groups | HD modality and period | AOPP | Ox-LDL | Free sulfhydryl | Protein carbonyls | TBARS/MDA | F2-isoprostanes | GSH | SOD | GPx | GR reductase | CAT | TAS |
|
Ward et al., 2003 [53] | 11 HD patients, (age 51 ± 5 yr) | (a) polysulfone membrane (b) cellulose membrane 49 ± 11 months | (a) 190 ± 37 (b) 163 ± 26 (μmol/L) | | (a) ↑425 ± 15 (b) ↑408 ± 23 (μmol/L) | (a) ↑0.175 ± 0.03 (b) ↑0.178 ± 0.04 (nmol/mg) | | | | | | | | |
|
Westhuyzen et al., 2003 [75] | 13 HD patients, (age: 69.2 ± 15.6 yr) | Vitamin E membrane, 3x/wk (a) Baseline (b) At 6 wk (c) At 13 wk | | | | | | | (a) 0.99 ± 0.17 (b) 1.08 ± 0.16 (c) 1.04 ± 0.20 (mmol/L) | (a) 725 ± 102 (b) 746 ± 130 (c) 771 ± 151 (U/g Hb) | (a) 46.8 ± 14.8 (b) ↑55.7 ± 14.8 (c) ↑56.7 ± 17.2 (U/g Hb) | | | |
|
Trimarchi et al., 2003 [71] | 12 HD patients, (age: 65.5 ± 13.1 yr) | Cellulose membrane, for 20.83 months, 3x/wk | | | | | 4.62 ± 0.9 (μmol/L) | | | | | | | |
|
Smith et al., 2003 [73] | 11 HD patients, (age: 64 ± 4 yr) | Polysulfone membrane, 3x/wk | | | | | | 602 ± 105 (pg/mL) | | | | | | |
|
Stepniewska et al., 2006 [55] | (a) 25 HD patients, (age: 50.3 ± 13.7 yr) (b) 26 HD patients (age: 60.5 ± 13.5 yr) | (a) Polysulfone membrane, glucose-free fluid, for 27.44 ± 15.87 months, 3x/week/4 h (b) Polysulfone glucose fluid, for 24.43 ± 12.68 months, 3x/week/4 h | | | | | | | (a) ↑18.3 ± 7.2 (b) 19.8 ± 8.2 (mmol/g Hb) | | | (a) 2.69 ± 0.95 (b) ↑2.05 ± 0.59 (U/g H) | | |
|
Huang et al., 2006 [76] | 25 HD patients, (age: 58 ± 3 yr) | HD for 12 months | | | | | | | | | | | | ↓0.5 (mmol/L) |
|
Malindretos et al., 2007 [74] | 20 HD patients, (age: 64.7 ± 17.3 yr): | Polysulfone membrane, 3x/wk/4 h | | 14.52 ± 8.3 (mU/L) | | | | | | | | | | |
|
Dolegowska et al., 2007 [50] | (a) 22 HD patients, (age: 53.1 ± 11.4 yr) (b) 22 HD patients, (age: 57.7 ± 14.7 yr) | (a) Polysulfone membrane, glucose-free fluid, 3x/week/4 h (b) Polysulfone glucose fluid, 3x/week/4 h | | | | | | (a) ↑Plasma: 0.18 ± 0.17 RBC: 7.40 ± 11.22 (b) Plasma: 0.16 ± 0.10 RBC: 7.62 ± 7.03 (ng/mL), (ng/g Hb) | | | | | | |
|
Ramos and Martínez-Castelao, 2008 [72] | 34 HD patients, (age: 57 ± 1 yr) | Cellulose membrane | | | | | 0.28 ± 0.19 (ng/g HDL) | | | | | | | |
|
Bober et al., 2010 [29] | (a) 22 HD patients, (age: 55.9 ± 14.8 yr) (b) 23 HD patients, (age: 64.3 ± 12.1 yr) | (a) Polysulfone membrane, glucose-free fluid, 3x/week (b) Polysulfone HD glucose fluid, 3x/week | | | | | (a) ↑2.01 ± 0.55 (b) ↓1.17 ± 0.31 (μmol/L) | | (a) ↓8.82 ± 2.22 (b) ↑11.07 ± 3.28 (nmol/g Hb) | | | | | |
|
Ogunro et al., 2014 [70] | (a) 35 HD patients, (age: 51.9 ± 12.4 yr) (b) 38 HD patients, (age: 49.8 ± 10.6 yr) | (a) Cellulose membrane (b) Polysulfonate membrane, 3x/wk/4-5 h | | | | | (a) ↑6.05 ± 0.9 (b) 4.71 ± 0.7 (nmol/mL) | | (a) ↓2.09 ± 0.3 (b) 3.68 ± 0.2 (μmol/g Hb) | (a) ↓378 ± 13.2 (b) ↓418 ± 19.7 (U/g Hb) | (a) 22.5 ± 3.1 (b) 27.5 ± 4.2 (U/g Hb) | | (a) 1231 ± 41.6 (b) ↑1370 ± 39.4 (U/g Hb) | (a) ↓1.0. ± 0.7 (b) 1.16 ± 0.2 (mmol/L trolox) |
|